Confidential
Target pathogen: ConfidentiaI
Indication: Undisclosed
Confidential
Target pathogen: Confidential
Indication: Undisclosed
Discovery
Lead optimization
Pre-clinical
Phase I
Phase II
Discovery
Lead optimization
Pre-clinical
Phase I
Phase II
ε²Phage program

